Filing Details
- Accession Number:
- 0001628280-25-024349
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-09 17:03:35
- Reporting Period:
- 2025-04-01
- Filing Date:
- 2025-05-09
- Accepted Time:
- 2025-05-09 17:03:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 1600 West End Ave. Suite 1300 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-04-01 | 8 | $4.24 | 5,698,914 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-02 | 8 | $4.39 | 5,698,922 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-03 | 8 | $4.21 | 5,698,930 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-04 | 8 | $4.23 | 5,698,938 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-07 | 8 | $4.19 | 5,698,946 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-08 | 8 | $4.14 | 5,698,954 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-09 | 8 | $4.09 | 5,698,962 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 8 | $4.01 | 5,698,970 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 8 | $4.02 | 5,698,978 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-14 | 10 | $4.03 | 5,698,988 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-15 | 10 | $4.14 | 5,698,998 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-16 | 10 | $4.23 | 5,699,008 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-17 | 10 | $4.61 | 5,699,018 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-21 | 10 | $4.79 | 5,699,028 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-22 | 10 | $4.74 | 5,699,038 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-23 | 10 | $5.01 | 5,699,048 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-24 | 10 | $5.12 | 5,699,058 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-25 | 10 | $4.94 | 5,699,068 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-28 | 8 | $4.91 | 5,699,076 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-29 | 8 | $4.93 | 5,699,084 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-30 | 8 | $4.79 | 5,699,092 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.
Billionaire Hedge Funds
